FDG-PET在诊断阿尔茨海默相关TDP-43蛋白病中的效用
本研究对73例阿尔茨海默谱系病理患者进行横断面神经影像-组织学分析,评估FDG-PET作为阿尔茨海默相关TDP-43蛋白病生前诊断工具的价值。结果显示TDP-43阳性与内侧颞叶和额叶代谢减低相关,结合这些区域的FDG-PET指标可能有助于生前预测。
要点
- TDP-43阳性病例在内侧颞叶、额上内侧和额眶上区域代谢减低更明显。
- 仅额眶上(FSO)和颞下/内侧颞(IMT)代谢与TDP-43阳性状态独立相关。
- IMT/FSO比值区分TDP-43阳性病例优于单独IMT(78% vs 48%)。
核心结论
- 阿尔茨海默相关TDP-43蛋白病与内侧颞叶和额叶代谢减低相关,联合FDG-PET指标可能有助于生前预测。
研究设计与样本
- 横断面神经影像-组织学分析,纳入73例来自Mayo Clinic阿尔茨海默病研究中心和衰老研究、具有阿尔茨海默谱系病理且生前接受FDG-PET和死后脑组织检查的患者。
主要发现
- 73例中27例(37%)为TDP-43阳性,其中6例(8%)伴有海马硬化。
- SPM分析显示TDP-43阳性病例在内侧颞叶、额上内侧和额眶上区域代谢减低更显著(p unc < 0.001)。
- 逻辑回归分析显示仅FSO和IMT与TDP-43阳性状态相关,可识别高达81%的TDP-43阳性病例(p < 0.001)。
- IMT/FSO比值区分TDP-43阳性病例的效能优于单独IMT(78% vs 48%)。
关键数值与推荐
- TDP-43阳性定义为杏仁核内存在TDP-43免疫反应性包涵体。
- SPM分析校正了场强、性别、Braak神经原纤维缠结和神经炎性斑块分期。
- 本研究提供Class II证据表明FDG-PET内侧颞叶和额叶代谢减低与阿尔茨海默相关TDP-43蛋白病相关。
临床怎么用
- 对于阿尔茨海默谱系患者,可考虑使用FDG-PET评估内侧颞叶和额叶代谢,辅助生前预测TDP-43蛋白病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate FDG-PET as an antemortem diagnostic tool for Alzheimer-related TAR DNA-binding protein of 43 kDa (TDP-43) proteinopathy. METHODS: We conducted a cross-sectional neuroimaging-histologic analysis of patients with antemortem FDG-PET and postmortem brain tissue from the Mayo Clinic Alzheimer's Disease Research Center and Study of Aging with Alzheimer spectrum pathology. TDP-43-positive status was assigned when TDP-43-immunoreactive inclusions were identified in the amygdala. Statistical parametric mapping (SPM) analyses compared TDP-43-positive (TDP-43[+]) with TDP-43-negative cases (TDP-43[-]), correcting for field strength, sex, Braak neurofibrillary tangle, and neuritic plaque stages. Cross-validated logistic regression analyses were used to determine whether regional FDG-PET values predict TDP-43 status. We also assessed the ratio of inferior temporal to medial temporal (IMT) metabolism as this was proposed as a biomarker of hippocampal sclerosis. RESULTS: Of 73 cases, 27 (37%) were TDP-43(+), of which 6 (8%) had hippocampal sclerosis. SPM analysis showed TDP-43(+) cases having greater hypometabolism of medial temporal, frontal superior medial, and frontal supraorbital (FSO) regions (p unc < 0.001). Logistic regression analysis showed only FSO and IMT to be associated with TDP-43(+) status, identifying up to 81% of TDP-43(+) cases (p < 0.001). An IMT/FSO ratio was superior to the IMT in discriminating TDP-43(+) cases: 78% vs 48%, respectively. CONCLUSIONS: Alzheimer-related TDP-43 proteinopathy is associated with hypometabolism in the medial temporal and frontal regions. Combining FDG-PET measures from these regions may be useful for antemortem prediction of Alzheimer-related TDP-43 proteinopathy. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that hypometabolism in the medial temporal and frontal regions on FDG-PET is associated with Alzheimer-related TDP-43 proteinopathy.
引用
- Buciuc M, Botha H, Murray ME, et al. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology. 2020. PMID: 32518145. doi:10.1212/WNL.0000000000009722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。